To assess the long-term follow-up of the globus pallidus internus (GPi) stimulation, six patients were evaluated every year by using the Unified Parkinson's Disease Rating Scale (UPDRS). Three years postoperatively, GPi stimulation led to a significant improvement of dyskinesia severity (50%, P = 0.
Bilateral high-frequency stimulation of the internal globus pallidus in advanced Parkinson's disease
β Scribed by Dr. J. Volkmann; V. Sturm; P. Weiss; J. Kappler; J. Voges; A. Koulousakis; R. Lehrke; H. Hefter; H.-J. Freund
- Publisher
- John Wiley and Sons
- Year
- 1998
- Tongue
- English
- Weight
- 1015 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Three patients with spasmodic torticollis (ST) obtained substantial benefit from bilateral globus pallidus internus (GPi) stimulation. Progressive improvement in ST occurred over several months but residual cervical dystonia remained. These results corroborate those obtained by Krauss e
We report the therapeutic effects of deep brain stimulation (DBS) in 2 patients with Parkinson's disease (PD) with severe end of dose dyskinesia that was resistant to medical therapy. In both patients, severe, end of day ballistic dyskinesias occurred when the last levodopa dose of the day was weari
## Abstract Our purpose was to measure the change in quality of life (QoL) following deep brain stimulation of the globus pallidus interna (GPiβDBS) in advanced Parkinson 's disease (PD), and identifies any associations with changes in motor features of the disease. Eleven patients (age range 54β69
High-frequency stimulation of the subthalamic nucleus (STN) is a promising therapeutic approach in patients with severely disabling Parkinson's disease (PD). Whereas STN stimulation improves the cardinal signs of PD, little is known about the effects of STN stimulation on fine manual skills like han
## Abstract We examined the impact of the subthalamic nuclei (STN) deep brain stimulation (DBS) on the healthβrelated quality of life (QoL) of patients with advanced Parkinson's disease (PD). Seventeen consecutive patients with refractory motor fluctuations and dyskinesia were included in the study